Jeffrey E. Russel

Array ( [id] => 7230179 [patent_doc_number] => 20040156839 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Antisense peptides to human fc receptors and their uses' [patent_app_type] => new [patent_app_number] => 10/399162 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3237 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0156/20040156839.pdf [firstpage_image] =>[orig_patent_app_number] => 10399162 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7338093 [patent_doc_number] => 20040132969 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Antibodies, peptides, analogs and uses thereof' [patent_app_type] => new [patent_app_number] => 10/450073 [patent_app_country] => US [patent_app_date] => 2004-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 20353 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132969.pdf [firstpage_image] =>[orig_patent_app_number] => 10450073 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7351227 [patent_doc_number] => 20040248797 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-09 [patent_title] => 'Pharmaceutical compositions of erythropoietin' [patent_app_type] => new [patent_app_number] => 10/775928 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12441 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0248/20040248797.pdf [firstpage_image] =>[orig_patent_app_number] => 10775928 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 741421 [patent_doc_number] => 07030084 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-18 [patent_title] => 'Drug-oligomer conjugates with polyethylene glycol components' [patent_app_type] => utility [patent_app_number] => 10/774903 [patent_app_country] => US [patent_app_date] => 2004-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14319 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/030/07030084.pdf [firstpage_image] =>[orig_patent_app_number] => 10774903 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 623795 [patent_doc_number] => 07138503 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-11-21 [patent_title] => 'Synthetic molecules that specifically react with target sequences' [patent_app_type] => utility [patent_app_number] => 10/772164 [patent_app_country] => US [patent_app_date] => 2004-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 10959 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/138/07138503.pdf [firstpage_image] =>[orig_patent_app_number] => 10772164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7285911 [patent_doc_number] => 20040146525 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Shellfish protein' [patent_app_type] => new [patent_app_number] => 10/472184 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7125 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146525.pdf [firstpage_image] =>[orig_patent_app_number] => 10472184 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7346553 [patent_doc_number] => 20040192600 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-30 [patent_title] => 'Combination of selective cox-2 inhibitor and lung surfactant for respiratory syndrome' [patent_app_type] => new [patent_app_number] => 10/485157 [patent_app_country] => US [patent_app_date] => 2004-01-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3731 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0192/20040192600.pdf [firstpage_image] =>[orig_patent_app_number] => 10485157 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5023482 [patent_doc_number] => 20070149448 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Use of the cathelicidin ll-37 and dervicaties thereof for would healing' [patent_app_type] => utility [patent_app_number] => 10/543659 [patent_app_country] => US [patent_app_date] => 2004-01-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 11447 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0149/20070149448.pdf [firstpage_image] =>[orig_patent_app_number] => 10543659 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7702980 [patent_doc_number] => 08088734 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2012-01-03 [patent_title] => 'Oral delivery of peptides' [patent_app_type] => utility [patent_app_number] => 10/761481 [patent_app_country] => US [patent_app_date] => 2004-01-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12106 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 130 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/088/08088734.pdf [firstpage_image] =>[orig_patent_app_number] => 10761481 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 689962 [patent_doc_number] => 07074432 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-07-11 [patent_title] => 'Method of modifying the release profile of sustained release compositions' [patent_app_type] => utility [patent_app_number] => 10/758717 [patent_app_country] => US [patent_app_date] => 2004-01-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 9395 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/074/07074432.pdf [firstpage_image] =>[orig_patent_app_number] => 10758717 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 492243 [patent_doc_number] => 07211269 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-05-01 [patent_title] => 'Cosmetic or dermatological use of peptides for promoting adhesion between skin cells' [patent_app_type] => utility [patent_app_number] => 10/755277 [patent_app_country] => US [patent_app_date] => 2004-01-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3366 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/211/07211269.pdf [firstpage_image] =>[orig_patent_app_number] => 10755277 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6997360 [patent_doc_number] => 20050137138 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-23 [patent_title] => 'E2F activity-inhibiting compound' [patent_app_type] => utility [patent_app_number] => 10/752505 [patent_app_country] => US [patent_app_date] => 2004-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10260 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20050137138.pdf [firstpage_image] =>[orig_patent_app_number] => 10752505 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 728652 [patent_doc_number] => 07041647 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-09 [patent_title] => 'Synthetic peptide having an ionophoric and antimicrobial activity' [patent_app_type] => utility [patent_app_number] => 10/751984 [patent_app_country] => US [patent_app_date] => 2004-01-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5931 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/041/07041647.pdf [firstpage_image] =>[orig_patent_app_number] => 10751984 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7150833 [patent_doc_number] => 20040171538 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-02 [patent_title] => 'Anticoagulants and their uses' [patent_app_type] => new [patent_app_number] => 10/470249 [patent_app_country] => US [patent_app_date] => 2004-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 7752 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0171/20040171538.pdf [firstpage_image] =>[orig_patent_app_number] => 10470249 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 672430 [patent_doc_number] => 07091325 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-15 [patent_title] => 'Fibrin/fibrinogen-binding conjugate' [patent_app_type] => utility [patent_app_number] => 10/749832 [patent_app_country] => US [patent_app_date] => 2003-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 5177 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/091/07091325.pdf [firstpage_image] =>[orig_patent_app_number] => 10749832 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5710944 [patent_doc_number] => 20060052289 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-09 [patent_title] => 'Use of somatostatin analogs in sleep apnea' [patent_app_type] => utility [patent_app_number] => 10/540358 [patent_app_country] => US [patent_app_date] => 2003-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3042 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20060052289.pdf [firstpage_image] =>[orig_patent_app_number] => 10540358 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7215720 [patent_doc_number] => 20050054580 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-10 [patent_title] => 'Methods for production of the oxidized glutathione composite with cis-diamminedichloroplatinum and pharmaceutical compositions based thereof regulating metabolism, proliferation, differentiation and apoptotic mechanisms for normal and transformed cells' [patent_app_type] => utility [patent_app_number] => 10/747855 [patent_app_country] => US [patent_app_date] => 2003-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 30317 [patent_no_of_claims] => 137 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0054/20050054580.pdf [firstpage_image] =>[orig_patent_app_number] => 10747855 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7410852 [patent_doc_number] => 20040176402 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-09 [patent_title] => 'Controlled-release compositions containing opioid agonist and antagonist' [patent_app_type] => new [patent_app_number] => 10/747865 [patent_app_country] => US [patent_app_date] => 2003-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21774 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20040176402.pdf [firstpage_image] =>[orig_patent_app_number] => 10747865 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5591405 [patent_doc_number] => 20060040857 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-23 [patent_title] => '1-Desamino-8-a-arginyl vasopressin analogs' [patent_app_type] => utility [patent_app_number] => 10/540841 [patent_app_country] => US [patent_app_date] => 2003-12-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3140 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0040/20060040857.pdf [firstpage_image] =>[orig_patent_app_number] => 10540841 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7004530 [patent_doc_number] => 20050169843 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-04 [patent_title] => 'Activatable imaging probes' [patent_app_type] => utility [patent_app_number] => 10/745336 [patent_app_country] => US [patent_app_date] => 2003-12-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 19698 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0169/20050169843.pdf [firstpage_image] =>[orig_patent_app_number] => 10745336 [rel_patent_id] =>[rel_patent_doc_number] =>)